80 hasil untuk "Bodei, Lisa"
Menampilkan 1–20 · 0,26 detik · RSS
-
Artikel Jurnal Teks lengkap
Landscape Analysis of Phase 2 and 3 Clinical Trials for Targeted Radionuclide Therapy
-
Artikel Jurnal Teks lengkap
Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on (68)Ga-DOTATATE PET/CT
(68)Ga-DOTATATE is a radiolabeled somatostatin analog used for the detection and characterization of somatostatin receptor (SSR)–overexpressing tumors, particularly well-differentiated neuroendocrine tumors. We present a case of a 65-year-old man with well-differentiated pancreatic neuroendocrine…
-
Artikel Jurnal Teks lengkap
Pharmacogenomics in Radionuclide Therapy: Impact on Response to Theranostics
-
Artikel Jurnal Teks lengkap
The Future of Targeted α-Therapy Is Bright, but Rigorous Studies Are Necessary to Advance the Field
-
Artikel Jurnal Teks lengkap
The Role of Theranostics in Prostate Cancer
Theranostics in men with metastatic castration-resistant prostate cancer (mCRPC) has been developed to target bone and the tumor itself. Currently, bone-directed targeted alpha therapy with radium-223 ((223)Ra) is the only theranostic agent proven to prolong survival in men with mCRPC who have…
-
Artikel Jurnal Teks lengkap
Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics
Prostate-specific membrane antigen (PSMA) is of considerable interest as a target for diagnostics and therapy of prostate cancer patients. PSMA-targeted imaging has demonstrable value in guiding the management of the clinical evolution of prostatic cancer. The use of PSMA-targeted therapy using…
-
Artikel Jurnal Teks lengkap
Integrating Early Rapid Post-Peptide Receptor Radionuclide Therapy Quality Assurance Scan into the Outpatient Setting
OBJECTIVE: To understand value of early rapid, quality-assurance (QA), post-therapy whole-body scan (Tx-WBS) in patients receiving peptide receptor radionuclide therapy (PRRT) in outpatient setting. METHODS: Sixteen patients with metastatic neuroendocrine tumors received PRRT and underwent Tx-WBS…
-
Artikel Jurnal Teks lengkap
Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes
Liver metastases are a major cause of death from colorectal cancer. Intraarterial therapy options for colorectal liver metastases include chemoinfusion via a hepatic arterial pump or port, irinotecan-loaded drug-eluting beads, and radioembolization using (90)Y microspheres. Intraarterial therapy…
-
Artikel Jurnal Teks lengkap
Seek and Find: Current Prospective Evidence for Prostate-specific Membrane Antigen Imaging to Detect Recurrent Prostate Cancer
CONTEXT: Men with biochemically relapsed prostate cancer face a clinical conundrum. Depending on the detected distribution of disease, treatment goals may range from cure with focal therapy to palliative with systemic therapy to expectant observation. Retrospective studies of prostate-specific…
-
Artikel Jurnal Teks lengkap
Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN), considered a heterogeneous neoplasia, exhibit ill-defined pathobiology and protean symptomatology and are ubiquitous in location. They are difficult to diagnose, challenging to manage, and outcome depends on cell type, secretory product…
-
Artikel Jurnal Teks lengkap
Blood transcript analysis and metastatic recurrent small bowel carcinoid management
BACKGROUND: Detection of neuroendocrine tumor (NET) disease progression is a key issue in determining management. Currently, assessment is by imaging (MRI/CT and Octreoscan®) and plasma Chromogranin A (CgA) measurement. CASE PRESENTATION: We report use of a NET-specific multigene PCR-derived blood…
-
Artikel Jurnal Teks lengkap
Enchondroma of tibia as potential false-positive finding on (68)Ga-DOTATOC PET/CT scan.
A 70-year-old man with history of carcinoid tumor of small bowel, was referred for (68)Ga-DOTATOC study to evaluate the extent of disease. PET/CT scan revealed known metastatic disease in liver, with other sites of involvement including pancreas, peritoneum and bones. In addition, moderately…
-
Artikel Jurnal Teks lengkap
The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors
Bronchopulmonary (BP) neuroendocrine tumors (NETs) comprise a spectrum of tumors that develop from respiratory neuroendocrine cells and represent ~20% of all lung neoplasia and ~30% of all NETs. The only curative treatment is surgical resection. For well-differentiated forms (typical and atypical…
-
Artikel Jurnal Teks lengkap
Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management
PURPOSE: The aim of this narrative review is to give an overview on current and emerging imaging methods and liquid biopsy for prediction and evaluation of response to PRRT. Current limitations and new perspectives, including artificial intelligence, are discussed. METHODS: A literature review of…
-
Artikel Jurnal Teks lengkap
Radiopharmaceutical therapy in cancer: clinical advances and challenges
Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach to treating many types of cancer. In RPT, radiation is systemically or locally delivered using pharmaceuticals that either bind preferentially to cancer cells or accumulate by physiological mechanisms. Almost…
-
Artikel Jurnal Teks lengkap
Author Correction: Radiopharmaceutical therapy in cancer: clinical advances and challenges
-
Artikel Jurnal Teks lengkap
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors
A critical requirement in neuroendocrine tumor (NET) management is a blood biomarker test that is sensitive, specific and reproducible. We evaluated a PCR-based 51-transcript signature to detect tumors, compared it with chromogranin A (CgA) and examined the confounding effect of proton pump…
-
Artikel Jurnal Teks lengkap
Radiopharmaceuticals for Cancer Diagnosis and Therapy:
Radiopharmaceutical therapy has emerged as a promising approach for the treatment of various cancers. The exploration of novel targets such as tumor-specific antigens, overexpressed receptors, and intracellular biomolecules using antibodies, peptides, or small molecules has expanded the scope of…
-
Artikel Jurnal Teks lengkap
Radiotheranostics in oncology: current challenges and emerging opportunities
Structural imaging remains an essential component of diagnosis, staging and response assessment in patients with cancer; however, as clinicians increasingly seek to noninvasively investigate tumour phenotypes and evaluate functional and molecular responses to therapy, theranostics — the combination…